Mr. Evert KÃœppers

Biography

 Prior to joining Oxyrane, Mr. Küppers was CEO of Swiss vaccine player Pevion Biotech AG. Previously, he was CEO of Munich-based Pieris AG, that he successfully restructured and refinanced, and Head of Business Development at IDEA AG for which he negotiated the largest German licensing deal in 2003 with Johnson & Johnson. Before joining the biotech industry, Mr. Küppers worked four years for BASF Pharma (now Abbott Laboratories) in International Operations (both at its German headquarters and Argentine subsidiary) and was a management consultant with the global pharmaceutical / health care team of AT Kearney in London, UK. Mr. Küppers holds an M.S. degree in Biomedical Sciences from Leiden University, The Netherlands, and an MBA from RSM/Erasmus University, The Netherlands.

Research Interest

Recombinant enzyme products, enzyme replacement therapies, lysosomal storage diseases (LSDs)